⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8147302 | 1.00 | — | — | |
| SCHEMBL22501020 | 0.80 | BHMT (0.41) | — | |
| SCHEMBL1881329 | 0.80 | SLC22A6 (0.48) | — | |
| SCHEMBL3613625 | 0.79 | — | — | |
| SCHEMBL9410982 | 0.79 | — | — | |
| SCHEMBL3007017 | 0.78 | TET2 (0.46) | — | |
| SCHEMBL4020826 | 0.78 | FOLH1 (0.42) | — | |
| SCHEMBL6439563 | 0.78 | SLC22A6 (0.43) | — | |
| SCHEMBL6439560 | 0.78 | SLC22A6 (0.43) | — | |
| SCHEMBL6728798 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| CN-118562045-A | Ceramic slurry binder powder for lithium battery, preparation method and application | 瑞固新能(上海)材料科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-116285786-A | Adhesive, preparation method, electrode slurry, electrode plate and secondary battery | 广汽埃安新能源汽车股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116003663-A | Long-chain carboxyl microsphere, preparation method thereof and kit | 博序医学科技(杭州)有限责任公司 | 2023-04-25 | — | — | CN | claimed |
| CN-114231198-A | High-molecular self-adhesive waterproof coiled material and preparation method thereof | 胡中兰 | 2022-03-25 | — | — | CN | claimed |
| CN-108164748-B | A kind of rubber bonding agent and its preparation and application | 同济大学 | 2019-12-03 | — | — | CN | claimed |
| CN-105742584-B | Composite anode active material, preparation method, cathode and lithium secondary battery | 三星电子株式会社 | 2019-06-28 | — | — | CN | claimed |
| US-10199638-B2 | Composite anode active material, method of preparing the same, and anode and lithium secondary battery including the composite anode active material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-02-05 | — | — | US | claimed |
| CN-108164748-A | A kind of rubber bonding agent and its preparation and application | 同济大学 | 2018-06-15 | — | — | CN | claimed |
| CN-108059688-A | A kind of nanometer additive and its preparation and application | 同济大学 | 2018-05-22 | — | — | CN | claimed |
| CN-105742584-A | Composite anode active material, method of preparing the same, and anode and lithium secondary battery | 三星电子株式会社 | 2016-07-06 | — | — | CN | claimed |
| US-20160190548-A1 | COMPOSITE ANODE ACTIVE MATERIAL, METHOD OF PREPARING THE SAME, AND ANODE AND LITHIUM SECONDARY BATTERY INCLUDING THE COMPOSITE ANODE ACTIVE MATERIAL | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | claimed |
| EP-2367835-B1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | CLARIANT FINANCE BVI LTD (VG) | 2013-12-11 | — | — | EP | claimed |
| EP-2367835-A1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | Clariant International Ltd. (CH) | 2011-09-28 | — | — | EP | claimed |
| WO-2010054722-A1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-05-20 | — | — | WO | claimed |
| US-20100022461-A1 | Novel Derivatives of Cyclic Compound And The Use Thereof | WONKISOPHARM CO., LTD. (KR) | 2010-01-28 | — | — | US | claimed |
| EP-1747059-A1 | PERVAPORATION COMPOSITE MEMBRANES | McMaster University (CA) | 2007-01-31 | — | — | EP | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | claimed |
| CN-116003663-B | Long-chain carboxyl microsphere, preparation method thereof and kit | 博序医学科技(杭州)有限责任公司 | 2025-11-14 | — | — | CN | disclosed |
| WO-2025215536-A1 | MACROCYCLIC PANRAS INHIBITORS FOR THE TREATMENT OF CANCER | NOVARTIS AG (CH) | 2025-10-16 | — | — | WO | disclosed |
| US-12404274-B2 | Macrocycles as factor xia inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-113912494-B | Preparation method and intermediate of 6-isopropenyl-3-methyl-9-decenyl acetate | 信越化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| US-20250057798-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2025-02-20 | — | — | US | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| US-12090131-B2 | Therapeutic use of compounds | UCL BUSINESS LTD (GB) | 2024-09-17 | — | — | US | disclosed |
| US-12091425-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2024-09-17 | — | — | US | disclosed |
| CN-118562045-A | Ceramic slurry binder powder for lithium battery, preparation method and application | 瑞固新能(上海)材料科技有限公司 | 2024-08-30 | — | — | CN | disclosed |
| WO-2024005572-A1 | REACTIVE NONIONIC SURFACTANT CONTAINING VINYL GROUP AND PROPYLENE OXIDE GROUP, AND ADHESIVE COMPOSITION COMPRISING SAME | 한국화학연구원 | 2024-01-04 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| US-11807602-B2 | Processes for preparing a 3-isopropenyl-6-heptenal compound and a 6- isopropenyl-3-methyl-3,9-decadienyl carboxylate compound, and an intermediate therefor | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11795133-B2 | Process for preparing 6-isopropenyl-3-methyl-9-decenyl acetate, and intermediates therefor | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230304220-A1 | LOW WEIGHT MODULAR CARPET COMPONENTS AND METHODS OF MAKING THE SAME | ALADDIN MANUFACTURING CORPORATION | 2023-09-28 | — | — | US | disclosed |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2023-08-08 | — | — | US | disclosed |
| CN-111902414-B | Substituted oxopyridine derivatives | 拜耳制药股份公司 | 2023-08-04 | — | — | CN | disclosed |
| US-20230243094-A1 | LOW WEIGHT MODULAR CARPET COMPONENTS AND METHODS OF MAKING THE SAME | ALADDIN MANUFACTURING CORPORATION | 2023-08-03 | — | — | US | disclosed |
| CN-107973809-B | Macrocyclic compounds as factor XIA inhibitors | 百时美施贵宝公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-116285786-A | Adhesive, preparation method, electrode slurry, electrode plate and secondary battery | 广汽埃安新能源汽车股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116284527-A | Ultrahigh molecular weight polyolefin and preparation method thereof | 中国石油化工股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023101251-A1 | NONIONIC REACTIVE SURFACTANT, AQUEOUS ADHESIVE COMPOSITION COMPRISING SAME, AND PREPARATION METHODS THEREFOR | 한국화학연구원 | 2023-06-08 | — | — | WO | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| US-11649587-B2 | Low weight modular carpet components and methods of making the same | ALADDIN MANUFACTURING CORPORATION (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230146709-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2023-05-11 | — | — | US | disclosed |
| CN-116003663-A | Long-chain carboxyl microsphere, preparation method thereof and kit | 博序医学科技(杭州)有限责任公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-116003663-A | Long-chain carboxyl microsphere, preparation method thereof and kit | 博序医学科技(杭州)有限责任公司 | 2023-04-25 | — | — | CN | disclosed |
| EP-3943474-B1 | PROCESSES FOR PREPARING ALPHA-NECRODYL COMPOUNDS AND PROCESSES FOR PREPARING GAMMA-NECRODYL COMPOUNDS | SHINETSU CHEMICAL CO (JP) | 2023-03-29 | — | — | EP | disclosed |
| US-20230058729-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2023-02-23 | — | — | US | disclosed |
| US-20230052348-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2023-02-16 | — | — | US | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-20220396915-A1 | CARPET TILES FOR MINIMALLY PREPARED SUBFLOORS AND METHODS OF MAKING THE SAME | ALADDIN MANUFACTURING CORPORATION (US) | 2022-12-15 | — | — | US | disclosed |
| EP-4099873-A1 | CARPET TILES FOR MINIMALLY PREPARED SUBFLOORS AND METHODS OF MAKING THE SAME | Aladdin Manufacturing Corporation (US) | 2022-12-14 | — | — | EP | disclosed |
| US-11491127-B2 | Therapeutic use of compounds | UCL BUSINESS PLC (GB) | 2022-11-08 | — | — | US | disclosed |
| WO-2022227933-A1 | METHOD FOR PREPARING POLYMER, AND OBTAINED POLYMER | 中国石油化工股份有限公司 | 2022-11-03 | — | — | WO | disclosed |
| CN-114569726-B | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-10-28 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11419839-B2 | Therapeutic use of compounds | UCL BUSINESS LTD (GB) | 2022-08-23 | — | — | US | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| US-11370741-B2 | Processes for preparing alpha-necrodyl compounds and processes for preparing gamma-necrodyl compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| CN-109956850-B | Process for producing 3, 7-dimethyl-7-octenyl alcohol and 3, 7-dimethyl-7-octenyl carboxylate compound | 信越化学工业株式会社 | 2022-06-21 | — | — | CN | disclosed |
| US-20220185763-A1 | PROCESSES FOR PREPARING A 3-ISOPROPENYL-6-HEPTENAL COMPOUND AND A 6-ISOPROPENYL-3-METHYL-3,9-DECADIENYL CARBOXYLATE COMPOUND, AND AN INTERMEDIATE THEREFOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-4011858-A1 | PROCESSES FOR PREPARING A 3-ISOPROPENYL-6-HEPTENAL COMPOUND AND A 6-ISOPROPENYL-3-METHYL-3,9-DECADIENYL CARBOXYLATE COMPOUND, AND AN INTERMEDIATE THEREFOR | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-06-15 | — | — | EP | disclosed |
| CN-114621073-A | Preparation method of heptenal compound, decadienyl carboxylate compound and intermediate thereof | 信越化学工业株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-114591223-A | Beta-lactamase inhibitor compounds | 恩塔西斯治疗有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-11306107-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2022-04-19 | — | — | US | disclosed |
| CN-114231198-A | High-molecular self-adhesive waterproof coiled material and preparation method thereof | 胡中兰 | 2022-03-25 | — | — | CN | disclosed |
| CN-114231198-A | High-molecular self-adhesive waterproof coiled material and preparation method thereof | 胡中兰 | 2022-03-25 | — | — | CN | disclosed |
| US-11260621-B2 | Low weight modular carpet components and methods of making the same | ALADDIN MANUFACTURING CORPORATION (US) | 2022-03-01 | — | — | US | disclosed |
| US-20220024847-A1 | PROCESSES FOR PREPARING ALPHA-NECRODYL COMPOUNDS AND PROCESSES FOR PREPARING GAMMA-NECRODYL COMPOUNDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-01-27 | — | — | US | disclosed |
| EP-3943474-A1 | PROCESSES FOR PREPARING ALPHA-NECRODYL COMPOUNDS AND PROCESSES FOR PREPARING GAMMA-NECRODYL COMPOUNDS | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-01-26 | — | — | EP | disclosed |
| CN-113968784-A | Preparation method of alpha-cadaveric alcohol-based compound and preparation method of gamma-cadaveric alcohol-based compound | 信越化学工业株式会社 | 2022-01-25 | — | — | CN | disclosed |
| US-20220017447-A1 | PROCESS FOR PREPARING 6-ISOPROPENYL-3-METHYL-9-DECENYL ACETATE, AND INTERMEDIATES THEREFOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-01-20 | — | — | US | disclosed |
| EP-3936500-A1 | PROCESS FOR PREPARING 6-ISOPROPENYL-3-METHYL-9-DECENYL ACETATE, AND INTERMEDIATES THEREFOR | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-01-12 | — | — | EP | disclosed |
| CN-113912494-A | Preparation method of 6-isopropenyl-3-methyl-9-decenyl acetate and intermediate thereof | 信越化学工业株式会社 | 2022-01-11 | — | — | CN | disclosed |
| US-20210309614-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2021-10-07 | — | — | US | disclosed |
| US-11136327-B2 | Macrocycles as factor XIA inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-10-05 | — | — | US | disclosed |
| WO-2021158584-A1 | CARPET TILES FOR MINIMALLY PREPARED SUBFLOORS AND METHODS OF MAKING THE SAME | ALADDIN MANUFACTURING CORPORATION (US) | 2021-08-12 | — | — | WO | disclosed |
| EP-3862482-A1 | CARPET TILES FOR WET SUBFLOORS AND METHODS OF MAKING THE SAME | Aladdin Manufacturing Corporation (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20210230189-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2021-07-29 | — | — | US | disclosed |
| CN-109563357-B | Aqueous composition and compact process for forming multi-component composite coating composition on substrate | PPG工业俄亥俄公司 | 2021-03-09 | — | — | CN | disclosed |
| US-10941117-B2 | 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2021-03-09 | — | — | US | disclosed |
| EP-3786165-A1 | SYNTHETIC INTERMEDIATES FOR PRODUCING MACROCYCLES AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2021-03-03 | — | — | EP | disclosed |
| EP-2737901-B1 | Therapeutic Use of Compounds | UCL BUSINESS LTD (GB) | 2021-03-03 | — | — | EP | disclosed |
| EP-3505506-B1 | METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENOL AND METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENYL CARBOXYLATE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2021-02-03 | — | — | EP | disclosed |
| US-20200308762-A1 | LOW WEIGHT MODULAR CARPET COMPONENTS AND METHODS OF MAKING THE SAME | ALADDIN MANUFACTURING CORPORATION | 2020-10-01 | — | — | US | disclosed |
| US-20200268699-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2020-08-27 | — | — | US | disclosed |
| EP-2552978-B1 | WATERBORNE HYBRID POLYMER DISPERSION | ALLNEX NETHERLANDS BV (NL) | 2020-08-26 | — | — | EP | disclosed |
| EP-2534154-B1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20200216397-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2020-07-09 | — | — | US | disclosed |
| CN-111356924-A | Method for detecting inflammatory body proteins as biomarkers for neurological disorders | 迈阿密大学 | 2020-06-30 | — | — | CN | disclosed |
| US-20200197344-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2020-06-25 | — | — | US | disclosed |
| CN-107074821-B | Diamide macrocycles as FXIA inhibitors | 百时美施贵宝公司 | 2020-05-22 | — | — | CN | disclosed |
| EP-3636259-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS LTD (GB) | 2020-04-15 | — | — | EP | disclosed |
| US-20200087312-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB (US) | 2020-03-19 | — | — | US | disclosed |
| EP-3099686-B1 | MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-03-11 | — | — | EP | disclosed |
| US-10548866-B2 | Therapeutic use of compounds | UCL BUSINESS LTD (GB) | 2020-02-04 | — | — | US | disclosed |
| EP-3575294-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | Les Laboratoires Servier (FR) | 2019-12-04 | — | — | EP | disclosed |
| CN-108164748-B | A kind of rubber bonding agent and its preparation and application | 同济大学 | 2019-12-03 | — | — | CN | disclosed |
| EP-2642990-B1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS PLC (GB) | 2019-09-18 | — | — | EP | disclosed |
| EP-3505506-A1 | METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENOL AND METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENYL CARBOXYLATE COMPOUND | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-07-03 | — | — | EP | disclosed |
| CN-109956850-A | The production method of 3,7- dimethyl -7- matsutake alcohol and 3,7- dimethyl -7- octenyl carboxylate compound | 信越化学工业株式会社 | 2019-07-02 | — | — | CN | disclosed |
| CN-105742584-B | Composite anode active material, preparation method, cathode and lithium secondary battery | 三星电子株式会社 | 2019-06-28 | — | — | CN | disclosed |
| US-20190194099-A1 | METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENOL AND METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENYL CARBOXYLATE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10326138-B2 | Charge storage material, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2019-06-18 | — | — | US | disclosed |
| EP-3070087-B1 | INTERMEDIATES FOR THE SYNTHESIS OF CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20190077114-A1 | LOW WEIGHT MODULAR CARPET COMPONENTS AND METHODS OF MAKING THE SAME | MOHAWK CARPET, LLC | 2019-03-14 | — | — | US | disclosed |
| US-10208068-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-02-19 | — | — | US | disclosed |
| EP-3237406-B1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2019-02-06 | — | — | EP | disclosed |
| US-10199638-B2 | Composite anode active material, method of preparing the same, and anode and lithium secondary battery including the composite anode active material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-02-05 | — | — | US | disclosed |
| EP-3189047-B1 | DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-12-26 | — | — | EP | disclosed |
| US-10164258-B2 | Fused-ring quinone-substituted polynorbornene, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2018-12-25 | — | — | US | disclosed |
| US-10081623-B2 | Diamide macrocycles that are FXIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-09-25 | — | — | US | disclosed |
| US-20180258052-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2018-09-13 | — | — | US | disclosed |
| CN-108164748-A | A kind of rubber bonding agent and its preparation and application | 同济大学 | 2018-06-15 | — | — | CN | disclosed |
| US-20180148461-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-05-31 | — | — | US | disclosed |
| CN-108059688-A | A kind of nanometer additive and its preparation and application | 同济大学 | 2018-05-22 | — | — | CN | disclosed |
| CN-107973809-A | MACROCYCLES AS FACTOR XIA INHIBITORS | 百时美施贵宝公司 | 2018-05-01 | — | — | CN | disclosed |
| US-9944743-B2 | Waterborne hybrid polymer dispersion | ALLNEX NETHERLANDS B.V. (NL) | 2018-04-17 | — | — | US | disclosed |
| US-9926281-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2018-03-27 | — | — | US | disclosed |
| US-9907362-B2 | Articles of footwear | NIKE, INC. (US) | 2018-03-06 | — | — | US | disclosed |
| US-9902742-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-02-27 | — | — | US | disclosed |
| US-20180022753-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-01-25 | — | — | US | disclosed |
| US-9871253-B2 | Ion-conductive fused-ring quinone polymer, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2018-01-16 | — | — | US | disclosed |
| CN-102753555-B | Macrocycles as Factor XIA Inhibitors | 百时美施贵宝公司 | 2018-01-12 | — | — | CN | disclosed |
| US-20180002293-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2018-01-04 | — | — | US | disclosed |
| US-9802939-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-10-31 | — | — | US | disclosed |
| US-9803220-B2 | Production of alkenes from 3-hydroxy-1-carboxylic acids via 3-sulfonyloxy-1-carboxylic acids | GLOBAL BIOENERGIES (FR) | 2017-10-31 | — | — | US | disclosed |
| US-20170283403-A1 | DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-10-05 | — | — | US | disclosed |
| US-9777001-B2 | Macrocycles with aromatic P2′ groups as factor xia inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-10-03 | — | — | US | disclosed |
| WO-2017147410-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2017-08-31 | — | — | WO | disclosed |
| US-20170242338-A1 | ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-24 | — | — | US | disclosed |
| US-20170242338-A1 | ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3189047-A1 | DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170184964-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170184962-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170184963-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170174801-A1 | NON-CHEMICAL AMPLIFICATION TYPE RESIST COMPOSITION, NON-CHEMICAL AMPLIFICATION TYPE RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170174801-A1 | NON-CHEMICAL AMPLIFICATION TYPE RESIST COMPOSITION, NON-CHEMICAL AMPLIFICATION TYPE RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170174922-A1 | CONDUCTIVE MATERIAL AND SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170176858-A1 | PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, RESIST COMPOSITION AND RESIST FILM | FUJIFILM CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170176858-A1 | PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, RESIST COMPOSITION AND RESIST FILM | FUJIFILM CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170158712-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-06-08 | — | — | US | disclosed |
| EP-2661428-B1 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2017-06-07 | — | — | EP | disclosed |
| US-20170130070-A1 | CONDUCTIVE MATERIAL AND SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170130071-A1 | CONDUCTIVE MATERIAL AND SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170104214-A1 | FUSED-RING QUINONE-SUBSTITUTED POLYNORBORNENE, ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | WASEDA UNIVERSITY (JP) | 2017-04-13 | — | — | US | disclosed |
| US-20170096429-A1 | MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-04-06 | — | — | US | disclosed |
| US-9611274-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-04-04 | — | — | US | disclosed |
| US-20170077517-A1 | ION-CONDUCTIVE FUSED-RING QUINONE POLYMER, ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | WASEDA UNIVERSITY (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20170077518-A1 | CHARGE STORAGE MATERIAL, ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | WASEDA UNIVERSITY (JP) | 2017-03-16 | — | — | US | disclosed |
| EP-3099686-A1 | MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-12-07 | — | — | EP | disclosed |
| US-20160319079-A1 | CROSS-LINKABLE SILICONE COMPOSITION | WACKER CHEMIE AG (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160311957-A1 | WATERBORNE HYBRID POLYMER DISPERSION | NUPLEX RESINS B.V. | 2016-10-27 | — | — | US | disclosed |
| EP-3083856-A1 | CROSS-LINKABLE SILICONE COMPOSITION | Wacker Chemie AG (DE) | 2016-10-26 | — | — | EP | disclosed |
| EP-2721053-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-10-19 | — | — | EP | disclosed |
| EP-2721053-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-10-19 | — | — | EP | disclosed |
| US-9469615-B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | MERCK SHARP & DOHME CORP. (US) | 2016-10-18 | — | — | US | disclosed |
| US-20160298139-A1 | PRODUCTION OF ALKENES FROM 3-HYDROXYCARBOXYLIC ACIDS VIA 3-HYDROXYCARBOXYL-NUCLEOTIDYLIC ACIDS | Scientist of Fortune, S.A. (LU) | 2016-10-13 | — | — | US | disclosed |
| EP-3070087-A1 | INTERMEDIATES FOR THE SYNTHESIS OF CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-09-21 | — | — | EP | disclosed |
| EP-2226192-B1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL 1987 LTD (IL) | 2016-08-31 | — | — | EP | disclosed |
| CN-105742584-A | Composite anode active material, method of preparing the same, and anode and lithium secondary battery | 三星电子株式会社 | 2016-07-06 | — | — | CN | disclosed |
| US-20160190548-A1 | COMPOSITE ANODE ACTIVE MATERIAL, METHOD OF PREPARING THE SAME, AND ANODE AND LITHIUM SECONDARY BATTERY INCLUDING THE COMPOSITE ANODE ACTIVE MATERIAL | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160166009-A1 | Articles of Footwear | NIKE, INC. | 2016-06-16 | — | — | US | disclosed |
| US-9360753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-9328187-B2 | Waterborne hybrid polymer dispersion | NUPLEX RESINS B.V. (NL) | 2016-05-03 | — | — | US | disclosed |
| EP-2226116-B1 | Drying tube, preparation and use thereof | ORIDION MEDICAL 1987 LTD (IL) | 2016-04-20 | — | — | EP | disclosed |
| US-9295304-B2 | Articles of footwear | NIKE, INC. (US) | 2016-03-29 | — | — | US | disclosed |
| US-20160068544-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-03-10 | — | — | US | disclosed |
| WO-2016036893-A1 | DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-03-10 | — | — | WO | disclosed |
| CN-103702985-B | As CRTH 2the quinoxaline of receptor modulators and azaquinoxaline | MERCK SHARP & DOHME CORP. (US) | 2016-02-17 | — | — | CN | disclosed |
| EP-2739625-B1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-01-20 | — | — | EP | disclosed |
| US-9221818-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-12-29 | — | — | US | disclosed |
| US-9164383-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150291981-A1 | Production of Alkenes From 3-Hydroxy-1-Carboxylic Acids Via 3-Sulfonyloxy-1-Carboxylic Acids | GLOBAL BIOENERGIES (FR) | 2015-10-15 | — | — | US | disclosed |
| US-20150283519-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL 1987 LTD. (IL) | 2015-10-08 | — | — | US | disclosed |
| CN-102822219-B | Waterborne hybrid polymer dispersion | NUPLEX RESINS B.V. (NL) | 2015-08-19 | — | — | CN | disclosed |
| US-9108981-B2 | Cyclic P1 linkers as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-08-18 | — | — | US | disclosed |
| WO-2015116885-A1 | MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-08-06 | — | — | WO | disclosed |
| US-9090766-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD. (IL) | 2015-07-28 | — | — | US | disclosed |
| US-9067035-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2015-06-30 | — | — | US | disclosed |
| WO-2015090374-A1 | CROSS-LINKABLE SILICONE COMPOSITION | WACKER CHEMIE AG (DE) | 2015-06-25 | — | — | WO | disclosed |
| US-20150112058-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150057262-A1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2015-02-26 | — | — | US | disclosed |
| US-8946468-B2 | Process for producing ester compound having an internal unsaturated bond or cyclic olefin | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2015-02-03 | — | — | US | disclosed |
| US-8940720-B2 | Macrocycles as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-01-27 | — | — | US | disclosed |
| US-8901115-B2 | Cyclic P1 linkers as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-12-02 | — | — | US | disclosed |
| US-20140230652-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL (1987) LTD. (IL) | 2014-08-21 | — | — | US | disclosed |
| US-20140221338-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-08-07 | — | — | US | disclosed |
| US-8764888-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD. (IL) | 2014-07-01 | — | — | US | disclosed |
| US-20140163002-A1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| EP-2739628-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2014-06-11 | — | — | EP | disclosed |
| EP-2739625-A1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2014-06-11 | — | — | EP | disclosed |
| US-8747752-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2014-06-10 | — | — | US | disclosed |
| EP-2737901-A1 | Therapeutic Use of Compounds | UCL Business PLC (GB) | 2014-06-04 | — | — | EP | disclosed |
| EP-2721053-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2014-04-23 | — | — | EP | disclosed |
| CN-103702985-A | Quinoxalines and aza-quinoxalines as crth2 receptor modulators | MERCK SHARP & DOHME | 2014-04-02 | — | — | CN | disclosed |
| US-20130338523-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL (1987) LTD. (IL) | 2013-12-19 | — | — | US | disclosed |
| EP-2367835-B1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | CLARIANT FINANCE BVI LTD (VG) | 2013-12-11 | — | — | EP | disclosed |
| EP-2666795-A1 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2013-11-27 | — | — | EP | disclosed |
| US-20130303517-A1 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS | MERCK SHARP & DOHME LLC | 2013-11-14 | — | — | US | disclosed |
| US-20130303616-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL BUSINESS PLC (GB) | 2013-11-14 | — | — | US | disclosed |
| EP-2661428-A1 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS | Merck Sharp & Dohme Corp. (US) | 2013-11-13 | — | — | EP | disclosed |
| EP-2642990-A1 | THERAPEUTIC USE OF COMPOUNDS | UCL Business Plc. (GB) | 2013-10-02 | — | — | EP | disclosed |
| US-8540806-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2013-09-24 | — | — | US | disclosed |
| US-20130160328-A1 | Articles of Footwear | NIKE, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-20130142754-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-06-06 | — | — | US | disclosed |
| US-20130142754-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-06-06 | — | — | US | disclosed |
| US-20130142754-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2013-06-06 | — | — | US | disclosed |
| US-20130116589-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL (1987) LTD. (IL) | 2013-05-09 | — | — | US | disclosed |
| WO-2013022814-A1 | CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| WO-2013022818-A1 | NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2552978-A1 | WATERBORNE HYBRID POLYMER DISPERSION | Nuplex Resins B.V. (NL) | 2013-02-06 | — | — | EP | disclosed |
| US-8367792-B2 | Polysiloxane compound and method of producing the same | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8366811-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2013-02-05 | — | — | US | disclosed |
| US-20130029270-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130018127-A1 | WATERBORNE HYBRID POLYMER DISPERSION | NUPLEX RESINS B.V. (NL) | 2013-01-17 | — | — | US | disclosed |
| WO-2012173983-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012173983-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-12-20 | — | — | WO | disclosed |
| EP-2534154-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | Bristol-Myers Squibb Company (US) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316360-A1 | PROCESS FOR PRODUCING ESTER COMPOUND HAVING a,ß-UNSATURATED BOND | OSAKA UNIVERSITY (JP) | 2012-12-13 | — | — | US | disclosed |
| CN-102822219-A | Waterborne hybrid polymer dispersion | NUPLEX RESINS BV | 2012-12-12 | — | — | CN | disclosed |
| CN-102753555-A | Macrocycles as factor XIA inhibitors | BRISTOL MYERS SQUIBB CO | 2012-10-24 | — | — | CN | disclosed |
| US-20120208973-A1 | POLYSILOXANE COMPOUND AND METHOD OF PRODUCING THE SAME | OOTAKE NOBUMASA (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120202153-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-20120202153-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-20120178750-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME CORP. (US) | 2012-07-12 | — | — | US | disclosed |
| US-20120178750-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME CORP. (US) | 2012-07-12 | — | — | US | disclosed |
| WO-2012087861-A1 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS | MERCK SHARP & DOHME CORP. (US) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012069790-A1 | THERAPEUTIC USE OF COMPOUNDS | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2012-05-31 | — | — | WO | disclosed |
| US-8173758-B2 | Polysiloxane compound and method of producing the same | JNC CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8168649-B2 | Niacin receptor agonists, compositions containing such compounds and methods of treatment | Merk Sharp & Dohme Corp. (US) | 2012-05-01 | — | — | US | disclosed |
| US-8168649-B2 | Niacin receptor agonists, compositions containing such compounds and methods of treatment | Merk Sharp & Dohme Corp. (US) | 2012-05-01 | — | — | US | disclosed |
| US-20120041190-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-02-16 | — | — | US | disclosed |
| WO-2011121085-A1 | WATERBORNE HYBRID POLYMER DISPERSION | NUPLEX RESINS B.V. (NL) | 2011-10-06 | — | — | WO | disclosed |
| EP-2367835-A1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | Clariant International Ltd. (CH) | 2011-09-28 | — | — | EP | disclosed |
| WO-2011100401-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110178313-A1 | POLYSILOXANE COMPOUND AND METHOD OF PRODUCING THE SAME | OOTAKE NOBUMASA | 2011-07-21 | — | — | US | disclosed |
| US-7939617-B2 | Silsesquioxane derivative; electronic material, optical material, optoelectronic material, paint, and primer. | CHISSO CORPORATION (JP) | 2011-05-10 | — | — | US | disclosed |
| EP-1901731-B1 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK SHARP & DOHME (US) | 2011-03-02 | — | — | EP | disclosed |
| US-20100226824-A1 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2010-09-09 | — | — | US | disclosed |
| US-20100226823-A1 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2010-09-09 | — | — | US | disclosed |
| US-20100224066-A1 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2010-09-09 | — | — | US | disclosed |
| EP-2226192-A1 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| EP-2226116-A2 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| EP-2226341-A2 | Drying substances, preparation and use thereof | Oridion Medical 1987 Ltd. (IL) | 2010-09-08 | — | — | EP | disclosed |
| CN-101822948-A | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD | 2010-09-08 | — | — | CN | disclosed |
| CN-101822950-A | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD | 2010-09-08 | — | — | CN | disclosed |
| US-20100144778-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | disclosed |
| US-20100144778-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | disclosed |
| WO-2010054722-A1 | PROCESS FOR PREPARING MONO-ALLYL-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, SALTS AND ESTERS THEREOF WITH ALLYLIC COMPOUNDS, AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-05-20 | — | — | WO | disclosed |
| US-20100076005-A1 | ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES | UNIBIOSCREEN SA (BE) | 2010-03-25 | — | — | US | disclosed |
| US-20100022461-A1 | Novel Derivatives of Cyclic Compound And The Use Thereof | WONKISOPHARM CO., LTD. (KR) | 2010-01-28 | — | — | US | disclosed |
| US-7604746-B2 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2009-10-20 | — | — | US | disclosed |
| EP-2089395-A2 | NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES | UnibioScreen S.A. (BE) | 2009-08-19 | — | — | EP | disclosed |
| US-20080171846-A1 | Polysiloxane compound and method of producing the same | JNC CORPORATION (JP) | 2008-07-17 | — | — | US | disclosed |
| WO-2008043846-A2 | NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES | UNIBIOSCREEN SA (BE) | 2008-04-17 | — | — | WO | disclosed |
| US-7319129-B2 | Silsesquioxane derivative and process for producing the same | CHISSO CORPORATION (JP) | 2008-01-15 | — | — | US | disclosed |
| EP-1747059-A1 | PERVAPORATION COMPOSITE MEMBRANES | McMaster University (CA) | 2007-01-31 | — | — | EP | disclosed |
| WO-2007002557-A1 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-7038064-B2 | Process for producing hydroxylactones | DIACEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| US-20060052623-A1 | Having two cyclotetrasiloxne rings connected by O-Si groups obtained through hydrolysis and condensation of trifunctional hydrolyzable silicon compounds; functionalization; fireproofing, thermostability, weathproofing, photostability, dielectric, hardness, strength and chemical resistance | CHISSO CORPORATION (JP) | 2006-03-09 | — | — | US | disclosed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | disclosed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | disclosed |
| EP-1302469-B1 | PROCESS FOR PRODUCING HYDROXYLACTONE | DAICEL CHEM (JP) | 2005-03-30 | — | — | EP | disclosed |
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6737544-B1 | HEATING ABOVE MELTING POINT | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-18 | — | — | US | disclosed |
| US-20040024228-A1 | Process for producing hydroxylactones | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-02-05 | — | — | US | disclosed |
| US-6639070-B1 | 4-substituted 1,3,4-oxadiazines; herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| EP-1187819-B1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AG (DE) | 2003-07-23 | — | — | EP | disclosed |
| EP-1315733-A2 | METHOD FOR PRODUCING ANELLATED TETRAHYDRO-[1H]-TRIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-04 | — | — | EP | disclosed |
| EP-1302469-A1 | PROCESS FOR PRODUCING HYDROXYLACTONE | Daicel Chemical Industries, Ltd. (JP) | 2003-04-16 | — | — | EP | disclosed |
| US-6528455-B1 | Post or preemergence herbicides such as 3-(4-chloro-2-fluoro -5-(1-methoxycarbonyl-1-vinyloxy)phenyl)-1-methyl-6-trifluoro methyl-2,4-pyrimidinedione | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-04 | — | — | US | disclosed |
| EP-1218350-A1 | 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-03 | — | — | EP | disclosed |
| EP-1187819-A1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-20 | — | — | EP | disclosed |
| EP-1187820-A1 | SUBSTITUTED UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-20 | — | — | EP | disclosed |
| WO-2002020531-A2 | METHOD FOR PRODUCING ANELLATED TETRAHYDRO-[1H]-TRIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-14 | — | — | WO | disclosed |
| EP-1127053-A1 | NOVEL 1-ARYL-4-THIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | disclosed |
| EP-1123266-A1 | METHOD FOR DRYING PHENOXYMETHYLBENZOIC ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-16 | — | — | EP | disclosed |
| WO-2001053249-A1 | PROCESS FOR THE CARBONYLATION OF BUTADIENE AND/OR AT LEAST ONE BUTADIENE DERIVATIVE | DSM N.V. (NL) | 2001-07-26 | — | — | WO | disclosed |
| EP-1118607-A1 | Process for the carbonylation of butadiene and/or at least one butadiene derivative | DSM N.V. (NL) | 2001-07-25 | — | — | EP | disclosed |
| WO-2001025216-A1 | 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-12 | — | — | WO | disclosed |
| WO-2001021569-A1 | PROCESS FOR THE PREPARATION OF 3-PENTENOIC ACID AND/OR ESTER THEREOF STARTING FROM BUTADIENE | DSM N.V. (NL) | 2001-03-29 | — | — | WO | disclosed |
| EP-0835248-B1 | 1-AMINO-3-BENZYLURACILS | BASF AG (DE) | 2001-02-21 | — | — | EP | disclosed |
| WO-2001000600-A1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | disclosed |
| WO-2001000602-A1 | SUBSTITUTED UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | disclosed |
| US-6150303-A | Substituted 3-phenylisoxazolines | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | disclosed |
| EP-1034166-A1 | SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES | BASF AKTIENGESELLSCHAFT (DE) | 2000-09-13 | — | — | EP | disclosed |
| WO-2000026194-A1 | NOVEL 1-ARYL-4-THIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-11 | — | — | WO | disclosed |
| EP-0998468-A1 | SUBSTITUTED 3-PHENYL ISOXAZOLINES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-10 | — | — | EP | disclosed |
| WO-2000023413-A1 | METHOD FOR DRYING PHENOXYMETHYLBENZOIC ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-27 | — | — | WO | disclosed |
| WO-1999018082-A1 | NOVEL SUBSTITUTED PYRIDAZINONES | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | disclosed |
| WO-1999014201-A1 | SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-25 | — | — | WO | disclosed |
| WO-1999005130-A1 | SUBSTITUTED 3-PHENYL ISOXAZOLINES | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | disclosed |
| EP-0891336-A1 | SUBSTITUTED 1-METHYL-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-20 | — | — | EP | disclosed |
| EP-0835248-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997035845-A1 | SUBSTITUTED 1-METHYL-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| EP-0293748-B1 | PROCESS FOR THE PREPARATION OF 2(5H)-FURANONES | BASF Aktiengesellschaft (DE) | 1992-01-29 | — | — | EP | disclosed |
| EP-0144252-B1 | PROCESS FOR THE OXYACYLATION OF BUTENES TO LINEAR ACETATES | Sun Refining and Marketing Company (US) | 1991-09-11 | — | — | EP | disclosed |
| US-5006511-A | Treating hypertension, congestive heart failure | MERCK & CO., INC. (US) | 1991-04-09 | — | — | US | disclosed |
| US-4853473-A | Preparation of 2(5H)-furanones | BASF AKTIENGESELLSCHAFT (DE) | 1989-08-01 | — | — | US | disclosed |
| EP-0312283-A2 | Di-or tripeptide renin inhibitors containing lactam conformational restrictions in ACHPA | MERCK & CO. INC. (US) | 1989-04-19 | — | — | EP | disclosed |
| US-4602103-A | PALLADIUM CATALYSTS | SUN REFINING AND MARKETING COMPANY (US) | 1986-07-22 | — | — | US | disclosed |
| EP-0090231-B1 | PROCESS FOR THE PREPARATION OF 3-ALKYL-2,5-DIHYDROFURAN-2-ONES | BASF Aktiengesellschaft (DE) | 1985-11-13 | — | — | EP | disclosed |
| EP-0144252-A1 | Process for the oxyacylation of butenes to linear acetates | Sun Refining and Marketing Company (US) | 1985-06-12 | — | — | EP | disclosed |
| US-4234741-A | BENZENESELENYL HALIDE REACTANT, SELENIUM-CONTAINING INTERMEDIATES | FIRMENICH, S.A. (CH) | 1980-11-18 | — | — | US | disclosed |
| US-4234741-A | BENZENESELENYL HALIDE REACTANT, SELENIUM-CONTAINING INTERMEDIATES | FIRMENICH, S.A. (CH) | 1980-11-18 | — | — | US | disclosed |